Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 21 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1532. Clear
Clear
Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues
View → Q1
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Health Issues
View → Q1
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues
View → Q4
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Health Issues
View → 4T
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View → Q4
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View → Q3
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Pharmacy
View → Q3
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Health Issues
View → Q3
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View → Q3
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues
View → Q2
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues
View → Q2
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Pharmacy
View → Q2
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View → Q2
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy
View → Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues
View → RR
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts
Pharmacy
View → Q1
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues
View → 1A
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Science/Technology
View → Q1
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View → Q1
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View → Q1
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Pharmacy
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem